DarioHealth Wins Fifth Fortune 50 Employer Contract
NEW YORK, July 16, 2026 DarioHealth Corp. has secured a major commercial milestone after being selected by another Fortune...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
Technology for New Therapy
NEW YORK, July 16, 2026 DarioHealth Corp. has secured a major commercial milestone after being selected by another Fortune...
TAMPA, Fla., July 16, 2026 Inspirata AI has officially unveiled its new corporate identity, transitioning from Inspirata to Inspirata...
HONG KONG & TAIPEI, Taiwan, July 14, 2026 Insilico Medicine and Bora Pharmaceuticals Co., Ltd. have announced a landmark...
SAN DIEGO, Calif., July 7, 2026 Nucleus Biologics has launched CRAICâ„¢ Formulation Finder, a new large language model (LLM)-powered...
FRANKLIN, Tenn., July 7, 2026 Kythera Labs has expanded its strategic partnership with Databricks by launching the Clinical Semantic...
LONDON, July 6, 2026 Clarivate Plc has announced a definitive agreement to sell its Life Sciences & Healthcare (LS&H)...
LAGUNA HILLS, California & SHANGHAI, China, July 6, 2026 Aureka, an AI TechBio company developing next-generation infrastructure for AI-driven...
PROVIDENCE, Rhode Island, July 6, 2026 Nabsys 2.0, LLC, a pioneer in electronic genome mapping (EGM) technology, has appointed...
NEW YORK, July 6, 2026 DarioHealth Corp. has announced a significant expansion of its digital health platform through a...
TARPON SPRINGS, Fla., June 30, 2026 Allarity Therapeutics, Inc. announced that the U.S. Patent and Trademark Office (USPTO) has...
